| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 8.02e-07 | 17 | 88 | 4 | GO:0072542 | |
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 8.22e-07 | 5 | 88 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 1.62e-06 | 20 | 88 | 4 | GO:0019211 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 1.64e-06 | 6 | 88 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 2.42e-06 | 22 | 88 | 4 | GO:0050998 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 6.82e-06 | 9 | 88 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 9.71e-06 | 10 | 88 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 2.29e-05 | 13 | 88 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 2.91e-05 | 14 | 88 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 4.44e-05 | 16 | 88 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 4.44e-05 | 16 | 88 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 6.43e-05 | 18 | 88 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 7.29e-05 | 98 | 88 | 5 | GO:0048306 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1E1 MYO1D MYO9A ATP6V1E2 DNAH17 RSF1 ZNFX1 AK9 ATP2A1 ABCC6 | 3.67e-04 | 614 | 88 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 3.92e-04 | 78 | 88 | 4 | GO:0043539 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 4.52e-04 | 81 | 88 | 4 | GO:0035254 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 8.99e-04 | 43 | 88 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 1.00e-03 | 100 | 88 | 4 | GO:0019888 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.38e-03 | 109 | 88 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 1.45e-03 | 13 | 88 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | translation initiation factor activity | 1.48e-03 | 51 | 88 | 3 | GO:0003743 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 1.57e-03 | 113 | 88 | 4 | GO:0019208 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 1.74e-03 | 54 | 88 | 3 | GO:0005246 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 2.39e-03 | 656 | 88 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 2.59e-03 | 62 | 88 | 3 | GO:0019829 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 4.27e-03 | 149 | 88 | 4 | GO:0030295 | |
| GeneOntologyMolecularFunction | DNA polymerase binding | 4.57e-03 | 23 | 88 | 2 | GO:0070182 | |
| GeneOntologyMolecularFunction | ATPase-coupled ion transmembrane transporter activity | 4.98e-03 | 24 | 88 | 2 | GO:0042625 | |
| GeneOntologyMolecularFunction | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism | 4.98e-03 | 24 | 88 | 2 | GO:0044769 | |
| GeneOntologyMolecularFunction | proton-transporting ATPase activity, rotational mechanism | 4.98e-03 | 24 | 88 | 2 | GO:0046961 | |
| GeneOntologyMolecularFunction | kinase activator activity | 5.38e-03 | 159 | 88 | 4 | GO:0019209 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 1.86e-08 | 8 | 85 | 4 | GO:1901842 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 6.75e-08 | 3 | 85 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 4.71e-07 | 16 | 85 | 4 | GO:1901841 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 6.71e-07 | 5 | 85 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 1.34e-06 | 6 | 85 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 1.34e-06 | 6 | 85 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 1.52e-06 | 21 | 85 | 4 | GO:1901386 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 5.57e-06 | 9 | 85 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 1.09e-05 | 11 | 85 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 1.45e-05 | 12 | 85 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 1.45e-05 | 12 | 85 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 1.78e-05 | 38 | 85 | 4 | GO:1901385 | |
| GeneOntologyBiologicalProcess | maintenance of organelle location | 1.87e-05 | 13 | 85 | 3 | GO:0051657 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 1.87e-05 | 13 | 85 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 1.98e-05 | 39 | 85 | 4 | GO:1901021 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 2.42e-05 | 41 | 85 | 4 | GO:1901020 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 3.22e-05 | 44 | 85 | 4 | GO:0070296 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 3.92e-05 | 92 | 85 | 5 | GO:1901019 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 4.41e-05 | 17 | 85 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | midbrain development | 5.05e-05 | 97 | 85 | 5 | GO:0030901 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 5.27e-05 | 18 | 85 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 6.24e-05 | 19 | 85 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 6.64e-05 | 167 | 85 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 8.38e-05 | 56 | 85 | 4 | GO:2001258 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 9.60e-05 | 111 | 85 | 5 | GO:0006942 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 9.83e-05 | 22 | 85 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 1.28e-04 | 24 | 85 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 1.64e-04 | 26 | 85 | 3 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 1.64e-04 | 26 | 85 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 1.88e-04 | 202 | 85 | 6 | GO:0006937 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 1.89e-04 | 69 | 85 | 4 | GO:1903170 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 2.05e-04 | 28 | 85 | 3 | GO:0010882 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 2.28e-04 | 29 | 85 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | heart contraction | 2.31e-04 | 298 | 85 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 2.53e-04 | 30 | 85 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.77e-04 | 217 | 85 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 2.79e-04 | 31 | 85 | 3 | GO:0010922 | |
| GeneOntologyBiologicalProcess | heart process | 2.88e-04 | 309 | 85 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 3.07e-04 | 32 | 85 | 3 | GO:0010800 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 3.37e-04 | 33 | 85 | 3 | GO:0010880 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 4.02e-04 | 35 | 85 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | negative regulation of ion transmembrane transporter activity | 4.61e-04 | 87 | 85 | 4 | GO:0032413 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 4.61e-04 | 87 | 85 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 4.62e-04 | 8 | 85 | 2 | GO:0016240 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 4.74e-04 | 37 | 85 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 5.02e-04 | 89 | 85 | 4 | GO:0055117 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 5.46e-04 | 91 | 85 | 4 | GO:0140115 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 5.55e-04 | 39 | 85 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transport | 5.70e-04 | 92 | 85 | 4 | GO:0051926 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 5.75e-04 | 249 | 85 | 6 | GO:0008016 | |
| GeneOntologyBiologicalProcess | mitochondrion-endoplasmic reticulum membrane tethering | 5.93e-04 | 9 | 85 | 2 | GO:1990456 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 6.95e-04 | 97 | 85 | 4 | GO:0032414 | |
| GeneOntologyBiologicalProcess | maintenance of location in cell | 7.07e-04 | 259 | 85 | 6 | GO:0051651 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 7.80e-04 | 100 | 85 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | substantia nigra development | 8.46e-04 | 45 | 85 | 3 | GO:0021762 | |
| GeneOntologyBiologicalProcess | cytoplasmic translational initiation | 8.46e-04 | 45 | 85 | 3 | GO:0002183 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 9.02e-04 | 46 | 85 | 3 | GO:0031952 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 1.00e-03 | 107 | 85 | 4 | GO:0032411 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 1.02e-03 | 48 | 85 | 3 | GO:0051281 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport | 1.08e-03 | 109 | 85 | 4 | GO:1904427 | |
| GeneOntologyBiologicalProcess | negative regulation of transporter activity | 1.11e-03 | 110 | 85 | 4 | GO:0032410 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.17e-03 | 392 | 85 | 7 | GO:0070588 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.19e-03 | 509 | 85 | 8 | GO:0006816 | |
| GeneOntologyBiologicalProcess | maintenance of location | 1.24e-03 | 396 | 85 | 7 | GO:0051235 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 1.29e-03 | 52 | 85 | 3 | GO:0010799 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.32e-03 | 400 | 85 | 7 | GO:0006936 | |
| GeneOntologyBiologicalProcess | negative regulation of cation transmembrane transport | 1.35e-03 | 116 | 85 | 4 | GO:1904063 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SCN11A ATP6V1E1 CALM1 SLC15A2 CALM2 CALM3 ATP6V1E2 DYSF SLC12A7 ATP2A1 CNGA2 | 1.39e-03 | 922 | 85 | 11 | GO:0098662 |
| GeneOntologyBiologicalProcess | cytokinesis | 1.56e-03 | 204 | 85 | 5 | GO:0000910 | |
| GeneOntologyCellularComponent | sarcomere | 8.63e-06 | 249 | 86 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 9.12e-06 | 179 | 86 | 7 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 9.12e-06 | 179 | 86 | 7 | GO:0030672 | |
| GeneOntologyCellularComponent | myofibril | 1.68e-05 | 273 | 86 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.59e-05 | 290 | 86 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | centrosome | PPP4R3B CCDC112 CALM1 CALM2 CALM3 CAPN7 LRRCC1 HYLS1 GPSM2 CTNNB1 DYSF PCNA | 7.18e-05 | 770 | 86 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | sperm midpiece | 1.41e-04 | 64 | 86 | 4 | GO:0097225 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 2.07e-04 | 293 | 86 | 7 | GO:0030658 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.34e-04 | 73 | 86 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | synaptic vesicle | 2.39e-04 | 300 | 86 | 7 | GO:0008021 | |
| GeneOntologyCellularComponent | exocytic vesicle | 3.52e-04 | 320 | 86 | 7 | GO:0070382 | |
| GeneOntologyCellularComponent | microtubule organizing center | PPP4R3B CCDC112 CALM1 CALM2 CALM3 CAPN7 LRRCC1 HYLS1 GPSM2 CTNNB1 DYSF PCNA | 3.71e-04 | 919 | 86 | 12 | GO:0005815 |
| GeneOntologyCellularComponent | cation channel complex | 4.21e-04 | 235 | 86 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | calyx of Held | 4.35e-04 | 36 | 86 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | growth cone | 5.24e-04 | 245 | 86 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex, eIF3m | 5.91e-04 | 9 | 86 | 2 | GO:0071541 | |
| GeneOntologyCellularComponent | site of polarized growth | 6.21e-04 | 253 | 86 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | extrinsic component of organelle membrane | 7.37e-04 | 43 | 86 | 3 | GO:0031312 | |
| GeneOntologyCellularComponent | nuclear body | PPP4R3B CCNDBP1 ORC3 ZNF638 CRTC1 TAB1 NCAPG2 SF3B2 EPAS1 KLHL20 PCNA | 1.17e-03 | 903 | 86 | 11 | GO:0016604 |
| GeneOntologyCellularComponent | A band | 1.28e-03 | 52 | 86 | 3 | GO:0031672 | |
| GeneOntologyCellularComponent | spindle pole | 1.58e-03 | 205 | 86 | 5 | GO:0000922 | |
| GeneOntologyCellularComponent | myosin complex | 1.85e-03 | 59 | 86 | 3 | GO:0016459 | |
| GeneOntologyCellularComponent | sperm flagellum | 1.91e-03 | 214 | 86 | 5 | GO:0036126 | |
| GeneOntologyCellularComponent | eukaryotic translation initiation factor 3 complex | 1.93e-03 | 16 | 86 | 2 | GO:0005852 | |
| GeneOntologyCellularComponent | eukaryotic 48S preinitiation complex | 2.45e-03 | 18 | 86 | 2 | GO:0033290 | |
| GeneOntologyCellularComponent | eukaryotic 43S preinitiation complex | 2.73e-03 | 19 | 86 | 2 | GO:0016282 | |
| GeneOntologyCellularComponent | proton-transporting two-sector ATPase complex, catalytic domain | 2.73e-03 | 19 | 86 | 2 | GO:0033178 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 3.02e-03 | 238 | 86 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | translation preinitiation complex | 3.03e-03 | 20 | 86 | 2 | GO:0070993 | |
| GeneOntologyCellularComponent | supramolecular fiber | ARHGAP4 MYL2 CALM1 CALM2 CALM3 MYO9A SPTBN1 DNAH17 CTNNB1 MYZAP DYSF ATP2A1 | 3.14e-03 | 1179 | 86 | 12 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | ARHGAP4 MYL2 CALM1 CALM2 CALM3 MYO9A SPTBN1 DNAH17 CTNNB1 MYZAP DYSF ATP2A1 | 3.32e-03 | 1187 | 86 | 12 | GO:0099081 |
| GeneOntologyCellularComponent | axolemma | 3.34e-03 | 21 | 86 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | presynapse | RAB35 SCN11A ATP6V1E1 CALM1 CALM2 CALM3 RABEP1 SGTA CTNNB1 DYSF | 3.42e-03 | 886 | 86 | 10 | GO:0098793 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.69e-03 | 378 | 86 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic vesicle membrane | 4.72e-03 | 25 | 86 | 2 | GO:0098850 | |
| HumanPheno | Polymorphic ventricular tachycardia | 2.62e-05 | 10 | 32 | 3 | HP:0031677 | |
| HumanPheno | 2:1 atrioventricular block | 3.82e-05 | 2 | 32 | 2 | HP:0034305 | |
| HumanPheno | Palpitations | 4.11e-05 | 106 | 32 | 6 | HP:0001962 | |
| HumanPheno | Abnormal T-wave | 7.33e-05 | 37 | 32 | 4 | HP:0005135 | |
| HumanPheno | Abnormality of the inner ear | MYL2 CALM1 CALM2 CALM3 MYO9A SPTBN1 COQ6 POLR1C KIAA1549 GPSM2 EIF3F CTNNB1 NCAPG2 ABCC6 SF3B2 EPAS1 PCNA | 8.85e-05 | 1102 | 32 | 17 | HP:0000359 |
| HumanPheno | Second degree atrioventricular block | 9.74e-05 | 15 | 32 | 3 | HP:0011706 | |
| HumanPheno | T-wave alternans | 1.14e-04 | 3 | 32 | 2 | HP:0012266 | |
| HumanPheno | Hypokalemia | 1.15e-04 | 79 | 32 | 5 | HP:0002900 | |
| HumanPheno | Abnormal electrophysiology of sinoatrial node origin | 1.29e-04 | 81 | 32 | 5 | HP:0011702 | |
| HumanPheno | Abnormal atrioventricular conduction | 1.35e-04 | 131 | 32 | 6 | HP:0005150 | |
| HumanPheno | Atrioventricular nodal disease | 1.35e-04 | 131 | 32 | 6 | HP:0005142 | |
| HumanPheno | Heart block | 1.66e-04 | 136 | 32 | 6 | HP:0012722 | |
| HumanPheno | Abnormal cardiac exercise stress test | 2.04e-04 | 19 | 32 | 3 | HP:0500018 | |
| HumanPheno | Vertigo | 2.45e-04 | 146 | 32 | 6 | HP:0002321 | |
| HumanPheno | Functional abnormality of the inner ear | MYL2 CALM1 CALM2 CALM3 MYO9A SPTBN1 COQ6 KIAA1549 GPSM2 EIF3F CTNNB1 NCAPG2 ABCC6 SF3B2 EPAS1 PCNA | 2.70e-04 | 1077 | 32 | 16 | HP:0011389 |
| HumanPheno | Abnormality of cardiac conduction | ATP6V1E1 MYL2 CALM1 CALM2 CALM3 VPS33A CTNNB1 DYSF ABCC6 EPAS1 | 2.95e-04 | 452 | 32 | 10 | HP:0001665 |
| HumanPheno | Arrhythmia | ATP6V1E1 MYL2 CALM1 CALM2 CALM3 ASL VPS33A CTNNB1 DYSF ABCC6 EPAS1 | 3.41e-04 | 553 | 32 | 11 | HP:0011675 |
| Domain | ATPase_V1/A1-cplx_esu | 1.95e-05 | 2 | 83 | 2 | IPR002842 | |
| Domain | vATP-synt_E | 1.95e-05 | 2 | 83 | 2 | PF01991 | |
| Domain | EFh | 6.94e-04 | 158 | 83 | 5 | SM00054 | |
| Domain | DUF4939 | 8.58e-04 | 10 | 83 | 2 | PF16297 | |
| Domain | Adenylat/UMP-CMP_kin | 8.58e-04 | 10 | 83 | 2 | IPR000850 | |
| Domain | DUF4939 | 8.58e-04 | 10 | 83 | 2 | IPR032549 | |
| Domain | LDOC1-rel | 1.05e-03 | 11 | 83 | 2 | IPR032567 | |
| Domain | EF_Hand_1_Ca_BS | 1.10e-03 | 175 | 83 | 5 | IPR018247 | |
| Domain | EF-hand_6 | 1.47e-03 | 13 | 83 | 2 | PF13405 | |
| Domain | EF-hand-dom_pair | 1.75e-03 | 287 | 83 | 6 | IPR011992 | |
| Domain | EF_HAND_1 | 2.16e-03 | 204 | 83 | 5 | PS00018 | |
| Domain | EF_HAND_2 | 3.68e-03 | 231 | 83 | 5 | PS50222 | |
| Domain | EF_hand_dom | 3.75e-03 | 232 | 83 | 5 | IPR002048 | |
| Domain | IQ | 3.89e-03 | 71 | 83 | 3 | PF00612 | |
| Domain | ARM-type_fold | 4.00e-03 | 339 | 83 | 6 | IPR016024 | |
| Domain | P-loop_NTPase | 4.28e-03 | 848 | 83 | 10 | IPR027417 | |
| Domain | EF-hand_1 | 4.71e-03 | 152 | 83 | 4 | PF00036 | |
| Domain | IQ | 5.63e-03 | 81 | 83 | 3 | SM00015 | |
| Domain | HRM | 6.84e-03 | 28 | 83 | 2 | PF02793 | |
| Domain | IQ_motif_EF-hand-BS | 7.53e-03 | 90 | 83 | 3 | IPR000048 | |
| Domain | IQ | 8.24e-03 | 93 | 83 | 3 | PS50096 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 5.07e-07 | 14 | 69 | 4 | MM15052 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.11e-06 | 5 | 69 | 3 | MM14493 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 2.22e-06 | 6 | 69 | 3 | MM14494 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 2.22e-06 | 6 | 69 | 3 | MM15662 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 3.87e-06 | 7 | 69 | 3 | MM1357 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 6.15e-06 | 25 | 69 | 4 | MM15574 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 8.47e-06 | 27 | 69 | 4 | MM15053 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 9.23e-06 | 9 | 69 | 3 | M3412 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 1.14e-05 | 29 | 69 | 4 | MM15219 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.31e-05 | 30 | 69 | 4 | MM15170 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 1.31e-05 | 10 | 69 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 1.31e-05 | 10 | 69 | 3 | M47954 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 1.80e-05 | 11 | 69 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.80e-05 | 11 | 69 | 3 | M47958 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 2.39e-05 | 12 | 69 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 2.39e-05 | 12 | 69 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 2.39e-05 | 12 | 69 | 3 | M47956 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 2.45e-05 | 35 | 69 | 4 | MM15114 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 3.10e-05 | 13 | 69 | 3 | MM15078 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 3.93e-05 | 14 | 69 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 3.93e-05 | 14 | 69 | 3 | M47388 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 3.93e-05 | 14 | 69 | 3 | MM1473 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 3.93e-05 | 14 | 69 | 3 | MM15391 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 4.90e-05 | 15 | 69 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 4.90e-05 | 15 | 69 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 4.90e-05 | 15 | 69 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 4.90e-05 | 15 | 69 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 4.90e-05 | 15 | 69 | 3 | MM14795 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 6.00e-05 | 16 | 69 | 3 | MM14492 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 6.00e-05 | 16 | 69 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 6.00e-05 | 16 | 69 | 3 | M47449 | |
| Pathway | REACTOME_CA2_PATHWAY | 6.73e-05 | 45 | 69 | 4 | MM15040 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 7.27e-05 | 17 | 69 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 7.27e-05 | 17 | 69 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 7.27e-05 | 17 | 69 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 7.27e-05 | 17 | 69 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 7.27e-05 | 17 | 69 | 3 | MM1372 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 7.27e-05 | 17 | 69 | 3 | M2349 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 8.69e-05 | 18 | 69 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 8.69e-05 | 18 | 69 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 8.69e-05 | 18 | 69 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 8.69e-05 | 18 | 69 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 8.69e-05 | 18 | 69 | 3 | M3430 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 9.03e-05 | 93 | 69 | 5 | MM15204 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.03e-04 | 19 | 69 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.03e-04 | 19 | 69 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 1.03e-04 | 19 | 69 | 3 | M47957 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.21e-04 | 20 | 69 | 3 | MM1445 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 1.38e-04 | 54 | 69 | 4 | MM15202 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 1.40e-04 | 21 | 69 | 3 | M11650 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 1.40e-04 | 21 | 69 | 3 | M47542 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.53e-04 | 165 | 69 | 6 | MM15026 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.62e-04 | 22 | 69 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 1.62e-04 | 22 | 69 | 3 | MM15519 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.71e-04 | 57 | 69 | 4 | MM15643 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.85e-04 | 23 | 69 | 3 | M47512 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 1.85e-04 | 23 | 69 | 3 | MM15222 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.91e-04 | 109 | 69 | 5 | MM15074 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.11e-04 | 24 | 69 | 3 | M47509 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.17e-04 | 112 | 69 | 5 | MM15214 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 2.17e-04 | 176 | 69 | 6 | MM15718 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.39e-04 | 25 | 69 | 3 | M1547 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.39e-04 | 25 | 69 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.39e-04 | 25 | 69 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 2.39e-04 | 25 | 69 | 3 | M47511 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 2.69e-04 | 26 | 69 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 2.69e-04 | 26 | 69 | 3 | M17941 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 2.69e-04 | 26 | 69 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 2.69e-04 | 26 | 69 | 3 | MM1371 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 2.69e-04 | 26 | 69 | 3 | MM1431 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 3.02e-04 | 27 | 69 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 3.02e-04 | 27 | 69 | 3 | M7739 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 3.35e-04 | 123 | 69 | 5 | MM14988 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 3.37e-04 | 28 | 69 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 3.37e-04 | 28 | 69 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 3.37e-04 | 28 | 69 | 3 | M47508 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 3.74e-04 | 29 | 69 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 3.74e-04 | 29 | 69 | 3 | M13494 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 3.74e-04 | 29 | 69 | 3 | MM1495 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 4.14e-04 | 30 | 69 | 3 | M9664 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 4.57e-04 | 31 | 69 | 3 | MM14896 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.67e-04 | 203 | 69 | 6 | M5485 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 5.03e-04 | 32 | 69 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 5.03e-04 | 32 | 69 | 3 | MM15143 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 5.17e-04 | 76 | 69 | 4 | MM15051 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | 5.44e-04 | 77 | 69 | 4 | MM14513 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 5.51e-04 | 33 | 69 | 3 | M9494 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 6.02e-04 | 34 | 69 | 3 | M10287 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 6.02e-04 | 34 | 69 | 3 | MM15985 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 6.02e-04 | 34 | 69 | 3 | MM1399 | |
| Pathway | REACTOME_RAF_ACTIVATION | 6.57e-04 | 35 | 69 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 6.57e-04 | 35 | 69 | 3 | MM15109 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 8.29e-04 | 150 | 69 | 5 | MM14889 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 9.04e-04 | 39 | 69 | 3 | MM14496 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 9.04e-04 | 39 | 69 | 3 | MM1397 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 9.04e-04 | 39 | 69 | 3 | M1908 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 9.74e-04 | 40 | 69 | 3 | M39595 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY | 1.04e-03 | 10 | 69 | 2 | M47739 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.06e-03 | 92 | 69 | 4 | MM14881 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 1.12e-03 | 42 | 69 | 3 | MM1504 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 29932249 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 1.62e-08 | 3 | 89 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 1.62e-08 | 3 | 89 | 3 | 9923700 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 1.62e-08 | 3 | 89 | 3 | 23893133 | |
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 1.62e-08 | 3 | 89 | 3 | 8573130 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 10899953 | ||
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 1.62e-08 | 3 | 89 | 3 | 9278050 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 15719022 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 1.62e-08 | 3 | 89 | 3 | 11847276 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 10416864 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 7828884 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 8862395 | ||
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 1.62e-08 | 3 | 89 | 3 | 2469574 | |
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 1.62e-08 | 3 | 89 | 3 | 15632291 | |
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 1.62e-08 | 3 | 89 | 3 | 8631777 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 18553937 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 14978283 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 1.62e-08 | 3 | 89 | 3 | 11054265 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 33191766 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 18940602 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 25268113 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 19651602 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 26969752 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 1.62e-08 | 3 | 89 | 3 | 11807546 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 8312049 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 37380439 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 1.62e-08 | 3 | 89 | 3 | 11710561 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 1.62e-08 | 3 | 89 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 1.62e-08 | 3 | 89 | 3 | 3384819 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 21799007 | ||
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 1.62e-08 | 3 | 89 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 1.62e-08 | 3 | 89 | 3 | 18786401 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 11072229 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 16229872 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 15063758 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 8226798 | ||
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 1.62e-08 | 3 | 89 | 3 | 17582331 | |
| Pubmed | PPP4R3B ORC3 UCHL5 PSMA2 NAT10 WDR70 RSF1 POLR1C AKR1C3 NCBP1 EIF3F CTNNB1 SF3B2 EIF3M PCNA | 4.30e-08 | 1014 | 89 | 15 | 32416067 | |
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 6.47e-08 | 4 | 89 | 3 | 7607248 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 27516456 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 6.47e-08 | 4 | 89 | 3 | 23040497 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 16299511 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 25437912 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 6.47e-08 | 4 | 89 | 3 | 15499021 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 10692436 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 16478480 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 6.47e-08 | 4 | 89 | 3 | 16127172 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 20226167 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 10823944 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 6.47e-08 | 4 | 89 | 3 | 25519244 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 6.47e-08 | 4 | 89 | 3 | 14960328 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 22405011 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 6.47e-08 | 4 | 89 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 6.47e-08 | 4 | 89 | 3 | 11807557 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 11286509 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 20953164 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 19855925 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 6.47e-08 | 4 | 89 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 6.47e-08 | 4 | 89 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 6.47e-08 | 4 | 89 | 3 | 8780394 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 19279214 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 6.47e-08 | 4 | 89 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 6.47e-08 | 4 | 89 | 3 | 20103772 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 9096366 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 12577052 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 6.47e-08 | 4 | 89 | 3 | 22067155 | |
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 25441029 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 16505387 | ||
| Pubmed | 6.47e-08 | 4 | 89 | 3 | 26164367 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | CALM1 MYO1D CALM2 CALM3 PSMA2 SPTBN1 NCBP1 EIF3F CTNNB1 ATP2A1 SF3B2 EIF3M | 1.00e-07 | 647 | 89 | 12 | 26618866 |
| Pubmed | SARS1 CALM1 MYO1D CALM2 CALM3 PSMA2 POLR1C NCBP1 TAB1 EIF3F ATP2A1 EIF3M GOLGA3 | 1.05e-07 | 786 | 89 | 13 | 29128334 | |
| Pubmed | PPP4R3B CALM1 RABEP1 SGTA SPTBN1 POLR1C AKR1C3 LRRCC1 GPSM2 NCBP1 ZNFX1 KDM4A ANKRD24 EIF3F SF3B2 GOLGA3 | 1.53e-07 | 1285 | 89 | 16 | 35914814 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 27165696 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 11981030 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 1.61e-07 | 5 | 89 | 3 | 11741295 | |
| Pubmed | Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. | 1.61e-07 | 5 | 89 | 3 | 19632986 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 3111527 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 17719545 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 35568036 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 25232683 | ||
| Pubmed | Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B. | 1.61e-07 | 5 | 89 | 3 | 20708613 | |
| Pubmed | Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis. | 1.61e-07 | 5 | 89 | 3 | 23446637 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 15140941 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 12034722 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 32522888 | ||
| Pubmed | Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. | 1.61e-07 | 5 | 89 | 3 | 10880439 | |
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 25703379 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 18570893 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 9242710 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 22705208 | ||
| Interaction | PHKA1 interactions | 1.26e-06 | 43 | 89 | 5 | int:PHKA1 | |
| Interaction | SPATA17 interactions | 2.88e-06 | 7 | 89 | 3 | int:SPATA17 | |
| Interaction | KCNN1 interactions | 4.59e-06 | 8 | 89 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 4.59e-06 | 8 | 89 | 3 | int:ARPP21 | |
| Interaction | MYO5B interactions | 6.34e-06 | 103 | 89 | 6 | int:MYO5B | |
| Interaction | USP18 interactions | 6.76e-06 | 60 | 89 | 5 | int:USP18 | |
| Interaction | IQCG interactions | 9.77e-06 | 10 | 89 | 3 | int:IQCG | |
| Interaction | VPS13C interactions | 1.39e-05 | 118 | 89 | 6 | int:VPS13C | |
| Interaction | NSMF interactions | 1.68e-05 | 35 | 89 | 4 | int:NSMF | |
| Interaction | C11orf65 interactions | 2.31e-05 | 13 | 89 | 3 | int:C11orf65 | |
| Interaction | ZNF280A interactions | 4.47e-05 | 16 | 89 | 3 | int:ZNF280A | |
| Interaction | DENND4A interactions | 4.90e-05 | 90 | 89 | 5 | int:DENND4A | |
| Interaction | CNGA2 interactions | 5.77e-05 | 3 | 89 | 2 | int:CNGA2 | |
| Interaction | CCND2 interactions | 6.45e-05 | 155 | 89 | 6 | int:CCND2 | |
| Interaction | CAMTA2 interactions | 6.48e-05 | 18 | 89 | 3 | int:CAMTA2 | |
| Interaction | ITGA6 interactions | 6.69e-05 | 156 | 89 | 6 | int:ITGA6 | |
| Interaction | NRGN interactions | 7.66e-05 | 19 | 89 | 3 | int:NRGN | |
| Interaction | ASPM interactions | 8.82e-05 | 164 | 89 | 6 | int:ASPM | |
| Interaction | CEP97 interactions | 9.12e-05 | 165 | 89 | 6 | int:CEP97 | |
| Interaction | PRIM1 interactions | 9.78e-05 | 104 | 89 | 5 | int:PRIM1 | |
| Interaction | NRIP1 interactions | 1.07e-04 | 170 | 89 | 6 | int:NRIP1 | |
| Interaction | ANKS6 interactions | 1.10e-04 | 56 | 89 | 4 | int:ANKS6 | |
| Interaction | KIF1B interactions | 1.18e-04 | 173 | 89 | 6 | int:KIF1B | |
| Interaction | APEX1 interactions | NPY2R CALM1 CALM3 MYO9A ORC3 ASL CBFA2T2 SPTBN1 NAT10 WDR70 RSF1 ADGRB2 ZNF638 BUD13 IQCN PCNA | 1.27e-04 | 1271 | 89 | 16 | int:APEX1 |
| Interaction | PCK1 interactions | 1.84e-04 | 119 | 89 | 5 | int:PCK1 | |
| Interaction | PLEKHA7 interactions | 1.84e-04 | 119 | 89 | 5 | int:PLEKHA7 | |
| Interaction | ATP6V1B1 interactions | 1.92e-04 | 120 | 89 | 5 | int:ATP6V1B1 | |
| Interaction | PPP1CB interactions | 2.27e-04 | 469 | 89 | 9 | int:PPP1CB | |
| Interaction | PPP3R1 interactions | 2.47e-04 | 69 | 89 | 4 | int:PPP3R1 | |
| Interaction | UHRF2 interactions | 2.60e-04 | 200 | 89 | 6 | int:UHRF2 | |
| Interaction | IQCN interactions | 2.61e-04 | 70 | 89 | 4 | int:IQCN | |
| Interaction | ANK3 interactions | 2.67e-04 | 201 | 89 | 6 | int:ANK3 | |
| Interaction | PPEF2 interactions | 2.80e-04 | 29 | 89 | 3 | int:PPEF2 | |
| Interaction | FAM83C interactions | 2.86e-04 | 6 | 89 | 2 | int:FAM83C | |
| Interaction | YAP1 interactions | CALM1 MYO1D CALM3 RABEP1 PSMA2 SPTBN1 NAT10 WDR70 POLR1C TAB1 EIF3F CTNNB1 SF3B2 PCNA | 3.02e-04 | 1095 | 89 | 14 | int:YAP1 |
| Interaction | USP20 interactions | 3.05e-04 | 206 | 89 | 6 | int:USP20 | |
| Interaction | TFRC interactions | 3.09e-04 | 489 | 89 | 9 | int:TFRC | |
| Interaction | ESCO1 interactions | 3.10e-04 | 30 | 89 | 3 | int:ESCO1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 1.53e-04 | 415 | 88 | 6 | chr12q24 | |
| Cytoband | 2p21 | 2.26e-04 | 61 | 88 | 3 | 2p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p21 | 5.03e-04 | 80 | 88 | 3 | chr2p21 | |
| Cytoband | 12q24.31 | 5.03e-04 | 80 | 88 | 3 | 12q24.31 | |
| Cytoband | 5p13.2 | 1.63e-03 | 31 | 88 | 2 | 5p13.2 | |
| GeneFamily | EF-hand domain containing | 5.78e-05 | 219 | 56 | 6 | 863 | |
| GeneFamily | Eukaryotic translation initiation factor 3 | 7.19e-04 | 13 | 56 | 2 | 1121 | |
| GeneFamily | Myosin light chains|EF-hand domain containing | 8.37e-04 | 14 | 56 | 2 | 657 | |
| GeneFamily | V-type ATPases | 2.29e-03 | 23 | 56 | 2 | 415 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP | 5.10e-06 | 200 | 88 | 7 | M3326 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 2.40e-05 | 17 | 88 | 3 | MM686 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RAB35 SARS1 CALM1 CALM2 SGTA PSMA2 NAT10 NCBP1 TAB1 CTNNB1 GFUS SF3B2 EIF3M GOLGA3 | 3.02e-05 | 1158 | 88 | 14 | MM1338 |
| Drug | purealin | 2.81e-09 | 58 | 89 | 7 | CID006419303 | |
| Drug | KT5926 | 1.41e-08 | 42 | 89 | 6 | CID000122126 | |
| Drug | pimonidazole | 4.16e-08 | 50 | 89 | 6 | CID000050981 | |
| Drug | NSC366363 | 5.77e-08 | 3 | 89 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 5.77e-08 | 3 | 89 | 3 | CID004630710 | |
| Drug | tatsiensine | 5.77e-08 | 3 | 89 | 3 | CID000163526 | |
| Drug | delcosine | 5.77e-08 | 3 | 89 | 3 | CID000120726 | |
| Drug | N-ethylmaleimide | ARHGAP4 MYL2 CALM1 MYO1D ART3 CALM2 CALM3 MYO9A ATP6V1E2 SPTBN1 GFUS SLC12A7 ATP2A1 | 9.36e-08 | 511 | 89 | 13 | CID000004362 |
| Drug | Nsc642900 | 2.30e-07 | 4 | 89 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 2.30e-07 | 4 | 89 | 3 | CID011779542 | |
| Drug | 85318-25-8 | 2.30e-07 | 4 | 89 | 3 | CID006439702 | |
| Drug | cloxacepride | 2.30e-07 | 4 | 89 | 3 | CID000068859 | |
| Drug | chloraniformethan | 2.30e-07 | 4 | 89 | 3 | CID000030331 | |
| Drug | Ti 233 | 2.30e-07 | 4 | 89 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 2.30e-07 | 4 | 89 | 3 | CID000080867 | |
| Drug | herbarumin III | 2.30e-07 | 4 | 89 | 3 | CID000643678 | |
| Drug | thiomethylpromazine | 2.30e-07 | 4 | 89 | 3 | CID000070583 | |
| Drug | KS-504e | 2.30e-07 | 4 | 89 | 3 | CID000129559 | |
| Drug | KS-504d | 2.30e-07 | 4 | 89 | 3 | CID000129557 | |
| Drug | Archanagelicine | 2.30e-07 | 4 | 89 | 3 | CID003083773 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 2.30e-07 | 4 | 89 | 3 | CID000127194 | |
| Drug | Roylin | 2.30e-07 | 4 | 89 | 3 | CID000099924 | |
| Drug | KS-502 | 2.30e-07 | 4 | 89 | 3 | CID000129242 | |
| Drug | KS-501 | 2.30e-07 | 4 | 89 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 2.30e-07 | 4 | 89 | 3 | CID000637889 | |
| Drug | PS-990 | 2.30e-07 | 4 | 89 | 3 | CID000157810 | |
| Drug | chlordecone | 2.48e-07 | 67 | 89 | 6 | CID000000299 | |
| Drug | AC1L9KB4 | 2.88e-07 | 15 | 89 | 4 | CID000446969 | |
| Drug | MAPTAM | 3.22e-07 | 37 | 89 | 5 | CID000123719 | |
| Drug | caged ATP | 3.23e-07 | 70 | 89 | 6 | CID000123806 | |
| Drug | jujubogenin | 5.74e-07 | 5 | 89 | 3 | CID005318721 | |
| Drug | D 890 | 5.74e-07 | 5 | 89 | 3 | CID000134083 | |
| Drug | NSC-36360 | 5.74e-07 | 5 | 89 | 3 | CID000133340 | |
| Drug | alpha-CAO | 5.74e-07 | 5 | 89 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 5.74e-07 | 5 | 89 | 3 | CID005356151 | |
| Drug | 4H-1,4-benzothiazin-3-one | 5.74e-07 | 5 | 89 | 3 | CID000021396 | |
| Drug | Y-acid | 5.74e-07 | 5 | 89 | 3 | CID000007022 | |
| Drug | C16AA | 5.74e-07 | 5 | 89 | 3 | CID000488017 | |
| Drug | auranthine | 5.74e-07 | 5 | 89 | 3 | CID000130919 | |
| Drug | Ant-ATP | 5.74e-07 | 5 | 89 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 5.74e-07 | 5 | 89 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 5.74e-07 | 5 | 89 | 3 | CID005748474 | |
| Drug | Ac-dvda | 5.74e-07 | 5 | 89 | 3 | CID000146768 | |
| Drug | VUF 4576 | 5.74e-07 | 5 | 89 | 3 | CID000132784 | |
| Drug | AC1NSV6X | 1.15e-06 | 6 | 89 | 3 | CID005317173 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 1.15e-06 | 6 | 89 | 3 | CID000004307 | |
| Drug | 2,5-diketocamphane | 1.15e-06 | 6 | 89 | 3 | CID000020218 | |
| Drug | benziodarone | 1.15e-06 | 6 | 89 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 1.15e-06 | 6 | 89 | 3 | CID000633347 | |
| Drug | CI-922 | 1.15e-06 | 6 | 89 | 3 | CID000146938 | |
| Drug | caged PE | 1.15e-06 | 6 | 89 | 3 | CID000192405 | |
| Drug | propyl-methylenedioxyindene | 1.15e-06 | 6 | 89 | 3 | CID000145934 | |
| Drug | MgCl2 | MYL2 SARS1 CALM1 MYO1D CALM2 CALM3 MYO9A PSMA2 SPTBN1 ATP2A1 | 1.24e-06 | 354 | 89 | 10 | CID000024584 |
| Drug | AC1L25Y6 | 1.82e-06 | 23 | 89 | 4 | CID000015465 | |
| Drug | lanthanum chloride hydrate | 1.82e-06 | 23 | 89 | 4 | CID000165791 | |
| Drug | quin2 | 1.98e-06 | 95 | 89 | 6 | CID000104841 | |
| Drug | EIPA | 1.98e-06 | 95 | 89 | 6 | CID000001795 | |
| Drug | 1-(4-pyridyl)ethanol | 2.00e-06 | 7 | 89 | 3 | CID000090919 | |
| Drug | AC1L52O2 | 2.00e-06 | 7 | 89 | 3 | CID000196983 | |
| Drug | chloronitromethane | 2.00e-06 | 7 | 89 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 2.00e-06 | 7 | 89 | 3 | CID000159622 | |
| Drug | DyCl3 | 2.00e-06 | 7 | 89 | 3 | CID000066207 | |
| Drug | DAPpNP | 2.00e-06 | 7 | 89 | 3 | CID005492375 | |
| Drug | T 7188 | 2.00e-06 | 7 | 89 | 3 | CID000003311 | |
| Drug | MS-857 | 2.00e-06 | 7 | 89 | 3 | CID000129517 | |
| Drug | SQ 65442 | 2.00e-06 | 7 | 89 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 2.00e-06 | 7 | 89 | 3 | CID000093048 | |
| Drug | O-4-(ethoxybutyl)berbamine | 2.00e-06 | 7 | 89 | 3 | CID000188375 | |
| Drug | TZC-5665 | 2.00e-06 | 7 | 89 | 3 | CID006449836 | |
| Drug | KHL-8430 | 2.00e-06 | 7 | 89 | 3 | CID000195711 | |
| Drug | CPU57 | 2.00e-06 | 7 | 89 | 3 | CID000195730 | |
| Drug | Drnflrfamide | 2.00e-06 | 7 | 89 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 2.00e-06 | 7 | 89 | 3 | CID003081980 | |
| Drug | asocainol | 2.00e-06 | 7 | 89 | 3 | CID000071161 | |
| Drug | cyhexatin | 2.59e-06 | 25 | 89 | 4 | CID005364545 | |
| Drug | AC1L1E3K | 2.66e-06 | 56 | 89 | 5 | CID000002625 | |
| Drug | NSC107658 | 3.15e-06 | 306 | 89 | 9 | CID000002919 | |
| Drug | calmidazolium chloride | 3.15e-06 | 160 | 89 | 7 | CID000002531 | |
| Drug | toxaphene | 3.17e-06 | 58 | 89 | 5 | CID005284469 | |
| Drug | proxyl nitroxide | 3.19e-06 | 8 | 89 | 3 | CID000076702 | |
| Drug | niludipine | 3.19e-06 | 8 | 89 | 3 | CID000089767 | |
| Drug | Ro 22-4839 | 3.19e-06 | 8 | 89 | 3 | CID000065839 | |
| Drug | HT-74 | 3.19e-06 | 8 | 89 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 3.19e-06 | 8 | 89 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 3.19e-06 | 8 | 89 | 3 | CID003085362 | |
| Drug | 3,7,8-trihydroxy-CPZ | 3.19e-06 | 8 | 89 | 3 | CID000467415 | |
| Drug | KS-504a | 3.19e-06 | 8 | 89 | 3 | CID000129577 | |
| Drug | NSP-805 | 3.19e-06 | 8 | 89 | 3 | CID000130349 | |
| Drug | w66 | 4.77e-06 | 9 | 89 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 4.77e-06 | 9 | 89 | 3 | CID000159916 | |
| Drug | adamantanone | 4.77e-06 | 9 | 89 | 3 | CID000064151 | |
| Drug | picumast | 4.77e-06 | 9 | 89 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 4.77e-06 | 9 | 89 | 3 | CID000440017 | |
| Drug | KS-505a | 4.77e-06 | 9 | 89 | 3 | CID003081782 | |
| Drug | trifluoperazine | 5.02e-06 | 324 | 89 | 9 | CID000005566 | |
| Drug | AC1L1IIA | 5.09e-06 | 172 | 89 | 7 | CID000004591 | |
| Drug | AC1L3X1Y | 6.33e-06 | 31 | 89 | 4 | CID000123655 | |
| Drug | Kr I | 6.79e-06 | 10 | 89 | 3 | CID005288675 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 6.79e-06 | 10 | 89 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 6.79e-06 | 10 | 89 | 3 | CID000062875 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.83e-06 | 10 | 86 | 3 | C1631597 | |
| Disease | hypertrophic cardiomyopathy 10 (implicated_via_orthology) | 8.35e-05 | 5 | 86 | 2 | DOID:0110316 (implicated_via_orthology) | |
| Disease | rhegmatogenous retinal detachment | 1.25e-04 | 6 | 86 | 2 | EFO_0005240 | |
| Disease | Hepatoblastoma | 1.25e-04 | 6 | 86 | 2 | C0206624 | |
| Disease | cancer (implicated_via_orthology) | 1.36e-04 | 268 | 86 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Phencyclidine-Related Disorders | 1.75e-04 | 7 | 86 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 1.75e-04 | 7 | 86 | 2 | C0031391 | |
| Disease | familial hypertrophic cardiomyopathy (is_implicated_in) | 2.98e-04 | 9 | 86 | 2 | DOID:0080326 (is_implicated_in) | |
| Disease | Cannabis Abuse | 3.72e-04 | 10 | 86 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 3.72e-04 | 10 | 86 | 2 | C0236735 | |
| Disease | Hashish Abuse | 3.72e-04 | 10 | 86 | 2 | C0018614 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 9.15e-04 | 147 | 86 | 4 | DOID:9352 (biomarker_via_orthology) | |
| Disease | Myopia | 9.27e-04 | 385 | 86 | 6 | HP_0000545 | |
| Disease | Romano-Ward Syndrome | 9.81e-04 | 16 | 86 | 2 | C0035828 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.10e-03 | 398 | 86 | 6 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Cannabis Dependence | 1.11e-03 | 17 | 86 | 2 | C0006870 | |
| Disease | uric acid measurement | 2.05e-03 | 610 | 86 | 7 | EFO_0004761 | |
| Disease | pulmonary embolism | 2.41e-03 | 25 | 86 | 2 | EFO_0003827 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FQVVSFMVDAENKEK | 666 | O60241 | |
| FMEVLAKEDTEAAIQ | 31 | P0C875 | |
| EIEKNDVVFSMDQTE | 346 | Q99814 | |
| ELKEQDQETMAFEAE | 441 | Q9BRD0 | |
| MEEIENAINTFKEEQ | 76 | Q8NEF3 | |
| MADQLTEEQIAEFKE | 1 | P0DP25 | |
| VQVFEFQLTAEDMKA | 281 | P42330 | |
| MAKDFQDIQQLSSEE | 1 | P07307 | |
| QDFQEFIAENETAVM | 311 | Q9H175 | |
| AANFSDKMDVIFVAE | 451 | Q8IWK6 | |
| LVSMDEEKFVDAVNS | 281 | Q9Y2Z9 | |
| ENFEKDETQMEVEAL | 466 | Q8TF21 | |
| ASFQEEIAQVGKEME | 186 | Q9P1Z9 | |
| MADQLTEEQIAEFKE | 1 | P0DP24 | |
| VAKTASEMVLADDNF | 726 | O14983 | |
| LFETSAKENVNVEEM | 146 | Q15286 | |
| AKENVNVEEMFNCIT | 151 | Q15286 | |
| ETAAKATVEQLMFEE | 786 | Q15276 | |
| VESQAFKNILVDEMD | 86 | Q9H0B3 | |
| AEADENQTVEEMKVE | 6 | P49146 | |
| QAERFSKEEVDQMFA | 126 | P10916 | |
| TSKEVAVNDDEMDNF | 146 | Q9HCM3 | |
| NDEDQVVVNKAAVMV | 161 | P35222 | |
| MTNDNKEADEDFFDI | 586 | P81274 | |
| VAMFENFVSVTQEED | 146 | Q09161 | |
| QEDKEAVFEVSDTMS | 326 | P04424 | |
| AVENKEISFDTMQQE | 286 | Q7L2H7 | |
| GKNVDVSENEMEEIF | 196 | Q9H2K0 | |
| QAMSEVQKAVAEAEQ | 451 | O43439 | |
| SNVDKEEEAVTIEMN | 186 | P12004 | |
| FEAEKEFNETMAQQA | 651 | O75164 | |
| SIKEAAEAVVEAMDF | 251 | Q13630 | |
| ESQEEELVKEVMAQF | 611 | Q9NX02 | |
| QADRFSEEEVKQMFA | 186 | Q9BUA6 | |
| FFNKVEIVSMLQEDE | 296 | Q5MIZ7 | |
| FDKEQMVAVTEANEA | 941 | Q08378 | |
| FNEVQEKAIEEQMVA | 906 | Q9H0A0 | |
| MNVQFQEDKESSFDV | 136 | Q96M11 | |
| KFTQHNFQEVMESEE | 191 | Q9Y2M5 | |
| KDDFANNREFITMVV | 596 | Q9Y6W3 | |
| DDINQEFKALMEDAV | 1521 | Q9UFH2 | |
| ESEDEVAVDMEFAKN | 141 | O00303 | |
| VDFVKDAHEEMEQAV | 181 | O95273 | |
| QAEETAAFEEVMKDL | 21 | Q6UUV9 | |
| ATMFFDEVVKQNVAA | 206 | Q96MF6 | |
| DSQPEKVMEAFNIDS | 2856 | Q8TDW7 | |
| MADQLTEEQIAEFKE | 1 | P0DP23 | |
| AFMEISAKTDVNVQE | 176 | O95661 | |
| EDSEFTKVEMDNLDN | 671 | Q96T23 | |
| VEVEQESFFEGKNMA | 56 | Q9Y666 | |
| FAVAAAVEIKINEMA | 391 | Q16348 | |
| DAVMDNVKQIFGFES | 396 | O75923 | |
| AFATVVTAAEKMDAN | 651 | Q9UBD5 | |
| MFVDENTFSNDALKV | 51 | Q9BWD3 | |
| MFVDENTFSNDALKV | 51 | Q17RB0 | |
| KEVMQEVAQLSQFDE | 231 | P49591 | |
| QEEEEAFIAEMQMVA | 206 | Q5TCS8 | |
| NVESNFEADEKLVMD | 1241 | Q9C093 | |
| TEGNEQMKVENFEAA | 96 | O43765 | |
| ANIKERQDVFFDMEA | 81 | A0PK00 | |
| ADVSFFLKEANQDIM | 56 | Q14C87 | |
| NQEIAAMIDTEFAKQ | 306 | Q15750 | |
| VVEKEELNMIDNFFS | 726 | Q8NI08 | |
| LVAENAMNAEKAFVT | 556 | O95255 | |
| ANAQMDFQVEVTTEK | 716 | Q06033 | |
| EKNFRVDVVHMDENS | 46 | O15160 | |
| EVDKAVAQNMDSVFK | 866 | P98171 | |
| TTMDANEEKINAVVE | 1216 | Q01082 | |
| VESQFDDLMVEKEAV | 146 | Q8NF67 | |
| HAIEMDSEIQKQFEE | 366 | Q86XI2 | |
| DFQDEEQVKSFLENM | 6 | Q96BR5 | |
| ENEVATSMEVDVQEK | 586 | Q16280 | |
| QQMFEFDTKTSAKEE | 146 | Q9Y5K5 | |
| QQAQVEKEDFSDMVA | 851 | Q13435 | |
| TMFAQVESDDEEAKN | 631 | Q9NW82 | |
| KESFEGQMTEDNIEV | 196 | P25787 | |
| KDNEVDFNEFVVMVA | 66 | Q8WXG8 | |
| QKDFMVADDISVRQF | 41 | Q8IYU4 | |
| FTQEDEQLVQEKMEA | 1801 | Q9P2E3 | |
| TQQKDMVEVADFDFS | 366 | Q8N3G9 | |
| AAEIEAKEKMFQEAQ | 411 | Q9UI33 | |
| MAFIEQEANEKAEEI | 16 | P36543 | |
| VEQEFMSGIDTDKVN | 376 | Q96AX1 | |
| QTMVEAVAEVEKNET | 1256 | Q14966 | |
| MAFIEQEANEKAEEI | 16 | Q96A05 | |
| MDDAFKRQVDAIVEA | 956 | Q9C099 | |
| INDAAEFRVVADAMK | 241 | O94832 | |
| IFQVKAEVLDMADNA | 21 | Q13508 | |
| QVRDAAVQKDAFVMA | 1061 | B2RTY4 | |
| KVESSQEANAEVMRE | 226 | P0CAP1 |